Cerespectus™

Cerespectus™ is an early-stage medical device company and a pioneering force in the neurological health. It is dedicated to developing minimally invasive catheters that utilize real-time anatomic video feedback and fluoroscopic assistance for precise gene or drug therapy delivery in the central nervous system for the treatment of various neurological disorders. With approximately 1 in 6 people globally suffering from neurological disorders, our commitment lies in driving transformative solutions for targeted and safe therapy delivery. Leveraging the emergence of gene therapy treatments, we aim to optimize the therapy delivery process, particularly targeting the Cisterna Magna (base of the brain) which allows circumventing of the blood-brain barrier and enhanced biodistribution of gene therapy as compared to other infusion routes. This approach also reduces the insertion and delivery risks.